CN102085380A - 一种用于冠心病检测和治疗的纳米磁性粒子的制备方法 - Google Patents
一种用于冠心病检测和治疗的纳米磁性粒子的制备方法 Download PDFInfo
- Publication number
- CN102085380A CN102085380A CN2011100008527A CN201110000852A CN102085380A CN 102085380 A CN102085380 A CN 102085380A CN 2011100008527 A CN2011100008527 A CN 2011100008527A CN 201110000852 A CN201110000852 A CN 201110000852A CN 102085380 A CN102085380 A CN 102085380A
- Authority
- CN
- China
- Prior art keywords
- magnetic
- coronary heart
- specific recognition
- transition zone
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 36
- 238000001514 detection method Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000006249 magnetic particle Substances 0.000 title abstract 3
- 230000003511 endothelial effect Effects 0.000 claims abstract description 60
- 210000000130 stem cell Anatomy 0.000 claims abstract description 57
- 230000007704 transition Effects 0.000 claims abstract description 44
- 239000002122 magnetic nanoparticle Substances 0.000 claims abstract description 33
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 14
- 239000008280 blood Substances 0.000 claims abstract description 10
- 210000004369 blood Anatomy 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 8
- 239000002105 nanoparticle Substances 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- 230000036285 pathological change Effects 0.000 claims description 21
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 20
- 231100000915 pathological change Toxicity 0.000 claims description 20
- 210000003725 endotheliocyte Anatomy 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 12
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 11
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 9
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- -1 amino, carboxyl Chemical group 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 230000005408 paramagnetism Effects 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- ACTRVOBWPAIOHC-UHFFFAOYSA-N succimer Chemical compound OC(=O)C(S)C(S)C(O)=O ACTRVOBWPAIOHC-UHFFFAOYSA-N 0.000 claims description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- 229910001566 austenite Inorganic materials 0.000 claims description 3
- 229960003638 dopamine Drugs 0.000 claims description 3
- 229960002897 heparin Drugs 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- JSGPBRQYMLFVJQ-UHFFFAOYSA-N 2-sulfanylhexanoic acid Chemical compound CCCCC(S)C(O)=O JSGPBRQYMLFVJQ-UHFFFAOYSA-N 0.000 claims description 2
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 2
- XMHFCUKJRCQXGI-CIUDSAMLSA-N Asn-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O XMHFCUKJRCQXGI-CIUDSAMLSA-N 0.000 claims description 2
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims description 2
- 241000282326 Felis catus Species 0.000 claims description 2
- 102000006354 HLA-DR Antigens Human genes 0.000 claims description 2
- 108010058597 HLA-DR Antigens Proteins 0.000 claims description 2
- 101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 claims description 2
- RTIRBWJPYJYTLO-MELADBBJSA-N Leu-Lys-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N RTIRBWJPYJYTLO-MELADBBJSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims description 2
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims description 2
- UQGAAZXSCGWMFU-UBHSHLNASA-N Ser-Trp-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N UQGAAZXSCGWMFU-UBHSHLNASA-N 0.000 claims description 2
- VEVYMLNYMULSMS-AVGNSLFASA-N Ser-Tyr-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O VEVYMLNYMULSMS-AVGNSLFASA-N 0.000 claims description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 2
- 108010015663 TPS-peptide Proteins 0.000 claims description 2
- MECLEFZMPPOEAC-VOAKCMCISA-N Thr-Leu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MECLEFZMPPOEAC-VOAKCMCISA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 108010090333 leucyl-lysyl-proline Proteins 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 229910000077 silane Inorganic materials 0.000 claims description 2
- 229940005605 valeric acid Drugs 0.000 claims description 2
- LZHHZYDPMZEMRX-STQMWFEESA-N Pro-Tyr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O LZHHZYDPMZEMRX-STQMWFEESA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 6
- 210000002889 endothelial cell Anatomy 0.000 abstract description 6
- 239000003446 ligand Substances 0.000 abstract description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical group S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 238000012216 screening Methods 0.000 description 22
- 238000005516 engineering process Methods 0.000 description 18
- 108091008104 nucleic acid aptamers Proteins 0.000 description 17
- 230000000702 anti-platelet effect Effects 0.000 description 6
- 239000003146 anticoagulant agent Substances 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- 241001515965 unidentified phage Species 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012531 culture fluid Substances 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- JZOYFBPIEHCDFV-YUMQZZPRSA-N Gln-His Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 JZOYFBPIEHCDFV-YUMQZZPRSA-N 0.000 description 1
- 101100209986 Rattus norvegicus Slc18a1 gene Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000031877 prophase Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 102220023257 rs387907546 Human genes 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100008527A CN102085380B (zh) | 2010-12-30 | 2011-01-04 | 一种用于冠心病检测和治疗的纳米磁性粒子的制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010613308.5 | 2010-12-30 | ||
CN201010613308 | 2010-12-30 | ||
CN2011100008527A CN102085380B (zh) | 2010-12-30 | 2011-01-04 | 一种用于冠心病检测和治疗的纳米磁性粒子的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102085380A true CN102085380A (zh) | 2011-06-08 |
CN102085380B CN102085380B (zh) | 2012-09-05 |
Family
ID=44097539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100008527A Expired - Fee Related CN102085380B (zh) | 2010-12-30 | 2011-01-04 | 一种用于冠心病检测和治疗的纳米磁性粒子的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102085380B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512713A (zh) * | 2011-12-30 | 2012-06-27 | 西南交通大学 | 一种诱导可降解的血管支架表面内皮化系统 |
CN102841198A (zh) * | 2012-09-18 | 2012-12-26 | 武汉大学 | 一种灵敏简便检测细菌的方法 |
CN103887030A (zh) * | 2014-04-04 | 2014-06-25 | 华东理工大学 | 一种用于纯化并固定化组氨酸标签蛋白的磁性亲和纳米颗粒及其制备方法和应用 |
CN106620728A (zh) * | 2016-10-12 | 2017-05-10 | 东华大学 | 一种两性离子修饰的多功能Mn3O4纳米颗粒磁共振成像造影剂及其制备和应用 |
CN109568654A (zh) * | 2018-12-10 | 2019-04-05 | 济宁医学院 | 负载维甲酸的钆参杂四氧化三铁复合纳米粒子的制备方法 |
CN110423382A (zh) * | 2019-08-13 | 2019-11-08 | 湖南工业大学 | 一种双层生物质复合膜材料 |
CN111388667A (zh) * | 2020-03-09 | 2020-07-10 | 西南交通大学 | 一种四氧化三铁纳米粒子表面改性方法、改性材料及其应用 |
CN113740243A (zh) * | 2021-08-31 | 2021-12-03 | 中国海洋石油集团有限公司 | 深水天然气管道在高气相流速工况下的缓蚀剂评价方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709512A (zh) * | 2005-06-17 | 2005-12-21 | 广东工业大学 | 一种磁性纳米药物载体及其制备方法和该载体的应用 |
CN1888007A (zh) * | 2006-07-21 | 2007-01-03 | 上海师范大学 | 一种磁性荧光纳米微球及其制法和应用 |
CN101383212A (zh) * | 2008-06-30 | 2009-03-11 | 上海师范大学 | 超顺磁/荧光纳米粒子及其制备方法和应用 |
CN101786600A (zh) * | 2010-03-04 | 2010-07-28 | 长春理工大学 | 一种制备二氧化锡/氧化锌复合多晶纳米带的方法 |
-
2011
- 2011-01-04 CN CN2011100008527A patent/CN102085380B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709512A (zh) * | 2005-06-17 | 2005-12-21 | 广东工业大学 | 一种磁性纳米药物载体及其制备方法和该载体的应用 |
CN1888007A (zh) * | 2006-07-21 | 2007-01-03 | 上海师范大学 | 一种磁性荧光纳米微球及其制法和应用 |
CN101383212A (zh) * | 2008-06-30 | 2009-03-11 | 上海师范大学 | 超顺磁/荧光纳米粒子及其制备方法和应用 |
CN101786600A (zh) * | 2010-03-04 | 2010-07-28 | 长春理工大学 | 一种制备二氧化锡/氧化锌复合多晶纳米带的方法 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512713A (zh) * | 2011-12-30 | 2012-06-27 | 西南交通大学 | 一种诱导可降解的血管支架表面内皮化系统 |
CN102841198A (zh) * | 2012-09-18 | 2012-12-26 | 武汉大学 | 一种灵敏简便检测细菌的方法 |
CN103887030A (zh) * | 2014-04-04 | 2014-06-25 | 华东理工大学 | 一种用于纯化并固定化组氨酸标签蛋白的磁性亲和纳米颗粒及其制备方法和应用 |
CN106620728A (zh) * | 2016-10-12 | 2017-05-10 | 东华大学 | 一种两性离子修饰的多功能Mn3O4纳米颗粒磁共振成像造影剂及其制备和应用 |
CN106620728B (zh) * | 2016-10-12 | 2020-05-29 | 东华大学 | 一种两性离子修饰的多功能Mn3O4纳米颗粒磁共振成像造影剂及其制备和应用 |
CN109568654A (zh) * | 2018-12-10 | 2019-04-05 | 济宁医学院 | 负载维甲酸的钆参杂四氧化三铁复合纳米粒子的制备方法 |
CN110423382A (zh) * | 2019-08-13 | 2019-11-08 | 湖南工业大学 | 一种双层生物质复合膜材料 |
CN111388667A (zh) * | 2020-03-09 | 2020-07-10 | 西南交通大学 | 一种四氧化三铁纳米粒子表面改性方法、改性材料及其应用 |
CN111388667B (zh) * | 2020-03-09 | 2022-02-01 | 西南交通大学 | 一种四氧化三铁纳米粒子表面改性方法、改性材料及其应用 |
CN113740243A (zh) * | 2021-08-31 | 2021-12-03 | 中国海洋石油集团有限公司 | 深水天然气管道在高气相流速工况下的缓蚀剂评价方法 |
CN113740243B (zh) * | 2021-08-31 | 2024-02-20 | 中国海洋石油集团有限公司 | 深水天然气管道在高气相流速工况下的缓蚀剂评价方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102085380B (zh) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102085380A (zh) | 一种用于冠心病检测和治疗的纳米磁性粒子的制备方法 | |
Licha et al. | Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes | |
Högemann et al. | High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes | |
Schneider et al. | Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy | |
Giouroudi et al. | Recent progress in biomedical applications of magnetic nanoparticles | |
CN107022516A (zh) | 一种在细胞微囊泡表面修饰配体的方法 | |
CN106137970A (zh) | 一种具有表面增强拉曼散射功能的复合纳米材料及其制备方法 | |
CN104094119A (zh) | 用于胞内传递生物活性分子的官能化纳米粒子 | |
CN103055329B (zh) | 用于动脉粥样硬化易损斑块早期诊断的靶向磁性纳米探针的制备方法 | |
CN104274842B (zh) | 一种聚乙烯亚胺介导的多功能四氧化三锰纳米颗粒核磁共振造影剂的制备方法 | |
Liu et al. | Biocompatible iron oxide nanoring-labeled mesenchymal stem cells: an innovative magnetothermal approach for cell tracking and targeted stroke therapy | |
Yeo et al. | Nanosensors for regenerative medicine | |
CN104225630B (zh) | 适用于mri/pa及其他成像的多模式自组装纳米探针 | |
CN110585449A (zh) | 基于中性粒细胞的活细胞探针构建方法 | |
Yang et al. | Dual-modality and Noninvasive Diagnostic of MNP–PEG–Mn Nanoprobe for Renal Fibrosis Based on Photoacoustic and Magnetic Resonance Imaging | |
Shi et al. | Preparation of a 3D printable high-performance GelMA hydrogel loading with magnetic cobalt ferrite nanoparticles | |
CN114657116B (zh) | 一种噻唑烷形成化学介导的细胞表面多功能化修饰方法 | |
WO2017013037A1 (en) | Methods and means for the modification of cell surfaces | |
Jeong et al. | Cancer selective turn-on fluorescence imaging using a biopolymeric nanocarrier | |
CN116059408A (zh) | 一种以铁蛋白为载体的纳米磁共振成像造影剂及其制备方法和应用 | |
Fang et al. | Arginine–glycine–aspartate (RGD)-targeted positron-labeled dendritic polylysine nanoprobe for tumor PET imaging | |
CN104645363A (zh) | 一种叶酸靶向99mTc标记的锰基螯合物MR/SPECT双模态探针的制备方法 | |
CN116763938A (zh) | 细胞外囊泡核酸纳米药物递送系统、其制备方法及应用 | |
CN105963718A (zh) | 一种麦芽糖修饰的钆基螯合物mr造影剂的制备方法 | |
Krishnan et al. | Developing μSpherePlatform using a commercial hairbrush: an agarose 3d culture platform for deep-tissue imaging of prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU NORTHWEST JIAO TONG UNIVERSITY SCIENGCE AN Free format text: FORMER OWNER: SOUTHWEST JIAOTONG UNIVERSITY Effective date: 20120723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120723 Address after: A, Southwest Jiaotong University Science Park, No. 142 Jiao Gong Road, Sichuan, Chengdu, China Applicant after: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. Address before: 610031 Sichuan City, Chengdu Province, No. two North Ring Road, No. 111 Applicant before: Southwest Jiaotong University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU JIAODA MAIDIKE TECHNOLOGY CO., LTD. Effective date: 20130510 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130510 Address after: 610031, A, Southwest Jiaotong University Science Park, No. 142, pay road, Sichuan, Chengdu Patentee after: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. Patentee after: Chengdu Jiaoda Maidike Technology Co., Ltd. Address before: 610031, A, Southwest Jiaotong University Science Park, No. 142, pay road, Sichuan, Chengdu Patentee before: Chengdu Southwest Jiaotong University Tech Park Management Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 Termination date: 20200104 |
|
CF01 | Termination of patent right due to non-payment of annual fee |